Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „Baseline“
Suchtreffer
Begriffe & Kennungen
Olanzapine Glenmark · 4.8 · 11 Observed for fasting normal levels at baseline (< 1.016 mmol/l) which increased to high (≥ 1.467 14
Eintrag öffnenOlanzapine Glenmark · 4.8 · 13 Following short term treatment (median duration 22 days), weight gain ≥ 7 % of baseline body weight (kg) wa
Eintrag öffnenOlanzapine Glenmark · 4.8 · 13 Following short term treatment (median duration 22 days), weight gain ≥ 7 % of baseline body weight (kg) wa
Eintrag öffnenOlanzapine Glenmark · 4.8 · 13 Following short term treatment (median duration 22 days), weight gain ≥ 7 % of baseline body weight (kg) wa
Eintrag öffnenOlanzapine Glenmark · 4.8 · 13 Following short term treatment (median duration 22 days), weight gain ≥ 7 % of baseline body weight (kg) wa
Eintrag öffnenOlanzapine Glenmark · 4.8 · 13 Following short term treatment (median duration 22 days), weight gain ≥ 7 % of baseline body weight (kg) wa
Eintrag öffnenOlanzapine Glenmark · 4.8 · 13 Following short term treatment (median duration 22 days), weight gain ≥ 7 % of baseline body weight (kg) wa
Eintrag öffnenOlanzapine Glenmark · 4.8 · 27 14 Observed for fasting normal levels at baseline (< 1.016 mmol/l) which increased to high (≥ 1.467 mmol/l)
Eintrag öffnenOlanzapine Glenmark · 4.8 · 40 se 10 High uric acid 10 1 Clinically significant weight gain was observed across all baseline Body Mass Ind
Eintrag öffnenOlanzapine Glenmark · 4.8 · 42 15 Changes in total fasting cholesterol levels from normal at baseline (< 4.39 mmol/l) to high (≥ 5.17 mmol
Eintrag öffnenOlanzapine Glenmark · 4.8 · 57 15 Changes in total fasting cholesterol levels from normal at baseline (< 4.39 mmol/l) to high (≥ 5.17 mmol
Eintrag öffnenOlanzapine Glenmark · 4.8 · 72 15 Changes in total fasting cholesterol levels from normal at baseline (< 4.39 mmol/l) to high (≥ 5.17 mmol
Eintrag öffnenOlanzapine Glenmark · 4.8 · 85 1 Clinically significant weight gain was observed across all baseline Body Mass Index (BMI) categories. Fol
Eintrag öffnenOlanzapine Glenmark · 4.8 · 87 15 Changes in total fasting cholesterol levels from normal at baseline (< 4.39 mmol/l) to high (≥ 5.17 mmol
Eintrag öffnenOlanzapine Glenmark · 4.8 · Observed for fasting normal levels at baseline (< 1.016 mmol/l) which increased to high (≥ 1.467 14
Eintrag öffnenOlanzapine Glenmark · 4.8 · Observed for fasting normal levels at baseline (< 1.016 mmol/l) which increased to high (≥ 1.467 14
Eintrag öffnenOlanzapine Glenmark · 4.8 · Observed for fasting normal levels at baseline (< 1.016 mmol/l) which increased to high (≥ 1.467 14
Eintrag öffnenOlanzapine Glenmark · 4.8 · Observed for fasting normal levels at baseline (< 1.016 mmol/l) which increased to high (≥ 1.467 14
Eintrag öffnenOlanzapine Glenmark · 4.8 · mmol/l) and changes in fasting triglycerides from borderline at baseline (≥ 1.016 mmol/l - < 1.467 mmol/l) to
Eintrag öffnenOlanzapine Glenmark · 4.8 · mmol/l) and changes in fasting triglycerides from borderline at baseline (≥ 1.016 mmol/l - < 1.467 mmol/l) to
Eintrag öffnen